leadf
logo-loader
viewImagin Medical

Imagin Medical highlights the capabilities of its i/Blue Imaging System to detect bladder cancer

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) CEO Jim Hutchens tells Proactive he believes the surgical imaging company can increase the efficiency and accuracy of detecting cancer, specifically bladder cancer, with its i/Blue Imaging System.

Hutchens is hosting a virtual investor event with key opinion leaders to highlight the potential of the i/Blue™ Imaging System on Thursday, October 29, 2020 at 12:00 pm EST.

Quick facts: Imagin Medical

Price: 0.355 CAD

CSE:IME
Market: CSE
Market Cap: $3.17 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

FansUnite Entertainment pleased Canada taking a look at allowing single...

FansUnite Entertainment (CSE: FANS- OTCQB: FUNFF) President Darius Eghdami joined Steve Darling from Proactive with news the company is hailing the Canadian government’s decision to introduce legislation that would legalize single-event sports betting in Canada. Eghdami talks about why that...

1 hour, 1 minute ago

2 min read